Snyder Capital Management L P Acquires 69,835 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Snyder Capital Management L P increased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 6.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,194,802 shares of the company’s stock after acquiring an additional 69,835 shares during the period. Henry Schein comprises about 1.7% of Snyder Capital Management L P’s portfolio, making the stock its 21st largest holding. Snyder Capital Management L P’s holdings in Henry Schein were worth $82,680,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in HSIC. Invesco Ltd. lifted its position in shares of Henry Schein by 0.4% in the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock worth $343,468,000 after purchasing an additional 17,552 shares during the period. FMR LLC raised its stake in Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company’s stock worth $242,064,000 after buying an additional 217,143 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after buying an additional 14,876 shares during the period. Fiduciary Management Inc. WI boosted its position in Henry Schein by 7.2% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock valued at $172,193,000 after acquiring an additional 167,990 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in Henry Schein by 15.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,137,549 shares of the company’s stock valued at $147,920,000 after acquiring an additional 279,507 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on HSIC shares. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Finally, Barrington Research reissued an “outperform” rating and set a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and an average price target of $81.10.

Insider Buying and Selling

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $66.23 on Friday. The firm’s 50-day moving average price is $69.46 and its 200-day moving average price is $71.81. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a market cap of $8.11 billion, a PE ratio of 27.26, a PEG ratio of 2.13 and a beta of 0.84. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.66 EPS. As a group, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.